Evidence map›Paper›PMID 36196300›Full record

ArticleOpen forum infectious diseases2022

Disseminated

Arthur H Totten, Gulbu Uzel, Pavel P Khil, Jung-Ho Youn, Jennifer Treat, Craig D Soutar, Steven M Holland, John P Dekker, Christa S Zerbe

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Arthur H TottenClinical Center, National Institutes of Health, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-2979-7522
Gulbu UzelNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Pavel P KhilClinical Center, National Institutes of Health, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-4903-8777
Jung-Ho YounClinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Jennifer TreatNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Craig D SoutarClinical Center, National Institutes of Health, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-0532-4771
Steven M HollandNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0003-3207-5464
John P DekkerClinical Center, National Institutes of Health, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-3701-5228
Christa S ZerbeNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0003-4219-0503
National Institutes of Health · USNational Institutes of Health Clinical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immunodeficiencyMycoplasma oralephosphoinositide-3-kinase regulatory subunit 1PI3KR1

Identifiers

PMID36196300
PMCPMC9522676
OpenAlexW4296528220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.